Ignite Creation Date:
2024-05-06 @ 9:54 AM
Last Modification Date:
2024-10-26 @ 12:21 PM
Study NCT ID:
NCT03107988
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-09
First Post:
2017-03-21
Brief Title:
NANT 2015-02 A Phase 1 Study of Lorlatinib PF-06463922
Sponsor:
New Approaches to Neuroblastoma Therapy Consortium
Organization:
New Approaches to Neuroblastoma Therapy Consortium
Organization Data
Organization:
New Approaches to Neuroblastoma Therapy Consortium
Class:
OTHER
Study ID:
NANT2015-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
New Approaches to Neuroblastoma Therapy Consortium
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Cookies for Kids Cancer | OTHER |
| Pfizer | INDUSTRY |
| University of Southern California | OTHER |
| Solving Kids Cancer USEU | UNKNOWN |
| Childrens Neuroblastoma Cancer Foundation | UNKNOWN |
| The Band of Parents | UNKNOWN |
| The Evan Foundation | OTHER |
| Wades Army | UNKNOWN |
| Ronan Thompson Foundation | UNKNOWN |
| The Catherine Elizabeth Blair Memorial Foundation | UNKNOWN |